Characterization of interleukin-1 receptor antagonist isoform expression in the brain of lipopolysaccharide-treated rats

Neuroscience

Volumn 103, Issue 1, 2001, Pages 161-169

  Palin, K ^a   Pousset, F ^a   Verrier, D ^a   Dantzer, R ^a   Kelley, K ^b   Parnet, P ^a   Lestage, J ^a  

^a INSERM   (France)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Brain; Hippocampus; Hypothalamus; Interleukin 1 receptor antagonist; Lipopolysaccharide; Rat

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BRAIN PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ISOPROTEIN; MESSENGER RNA;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NERVE CELL; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MICROGLIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TIME;

BLOTTING, WESTERN; BRAIN; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; HYPOTHALAMUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIPOPOLYSACCHARIDES; PITUITARY GLAND; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; TIME FACTORS;

EID: 0035961224     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00544-3     Document Type: Article

References (45)

1. Interleukin-1 receptor antagonist: Role in biology
2. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat
3. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
4. Peripheral administration of lipopolysaccharide induces activation of microglial cells in rat brain
5. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein
6. IL-1 and its receptor are translocated to the nucleus
7. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
8. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction
9. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: Evolution of a cytokine control mechanism
10. Visualization and characterization of interleukin 1 receptors in brain
11. Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: Regulation by bacterial lipopolysaccharide (LPS) treatment
12. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 family and interleukin-6
13. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization
14. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats
15. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium
16. Expression of multiple forms of IL-1 receptor antagonist (IL-1ra) by human retinal pigment epithelial cells: Identification of a new IL-1ra exon
17. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain
18. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice
19. Localization of interleukin-1 receptor antagonist mRNA in rat brain
20. IFNs are critical regulators of IL-1 receptor antagonist and IL-1 expression in human microglia
21. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat
22. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist
23. Characterization of a low molecular weight isoform of IL-1 receptor antagonist
24. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta
25. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes
26. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats
27. The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts
28. Characterization of type II intracellular IL-1 receptor antagonist (IL-1ra3): A depot IL-1ra
29. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells
30. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice
31. A multispecific internal (pRat6) for the analysis of rat cytokine mRNA levels by quantitative RT-PCR
32. Developmental expression of cytokine genes in the cortex and hippocampus of the rat central nervous system
33. Effect of serotonin on cytokine mRNA expression in rat hippocampal astrocytes
34. Production of interleukin-1 receptor antagonist isoforms by microglia in mixed rat glial cells stimulated by lipopolysaccharide
35. Binding, internalization, and intracellular localization of interleukin-1 beta in human diploid fibroblasts
36. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
37. Cytokines in neurodegeneration and repair
38. Production of interleukin-1 receptor antagonist by human glioblastoma cells in vitro and in vivo
39. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat
40. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: A pathway for the induction of non-specific symptoms of sickness?
41. Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain
42. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta
43. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications